カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のダルファンプリジン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Dalfampridine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19255）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19255
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のダルファンプリジン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ダルファンプリジン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のダルファンプリジンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ダルファンプリジン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・10mg、その他

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界のダルファンプリジン市場の主要な市場プレーヤーは以下のとおりです。
・Acorda Therapeutics、Elan Pharma、Biogen、Sun Pharmaceutical、Aurobindo Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ダルファンプリジン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なダルファンプリジンメーカーの企業概要、2019年～2022年までのダルファンプリジンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なダルファンプリジンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ダルファンプリジンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのダルファンプリジンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのダルファンプリジン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびダルファンプリジンの産業チェーンを掲載しています。
・第13、14、15章では、ダルファンプリジンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ダルファンプリジンの概要
- 種類別分析（2017年vs2021年vs2028年）：10mg、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界のダルファンプリジン市場規模・予測
- 世界のダルファンプリジン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Acorda Therapeutics、Elan Pharma、Biogen、Sun Pharmaceutical、Aurobindo Pharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：10mg、その他
・用途別分析2017年-2028年：病院、診療所、その他
・ダルファンプリジンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ダルファンプリジンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ダルファンプリジンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ダルファンプリジンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ダルファンプリジンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Dalfampridine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Dalfampridine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Dalfampridine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 10 mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Dalfampridine include Acorda Therapeutics, Elan Pharma, Biogen, Sun Pharmaceutical, and Aurobindo Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dalfampridine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10 mg
Others
Market segment by Application can be divided into
Hospitals
Clinics
Others
The key market players for global Dalfampridine market are listed below:
Acorda Therapeutics
Elan Pharma
Biogen
Sun Pharmaceutical
Aurobindo Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dalfampridine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dalfampridine, with price, sales, revenue and global market share of Dalfampridine from 2019 to 2022.
Chapter 3, the Dalfampridine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dalfampridine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Dalfampridine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dalfampridine.
Chapter 13, 14, and 15, to describe Dalfampridine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Dalfampridine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dalfampridine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 10 mg
1.2.3 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Dalfampridine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Dalfampridine Market Size & Forecast
1.4.1 Global Dalfampridine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Dalfampridine Sales in Volume (2017-2028)
1.4.3 Global Dalfampridine Price (2017-2028)
1.5 Global Dalfampridine Production Capacity Analysis
1.5.1 Global Dalfampridine Total Production Capacity (2017-2028)
1.5.2 Global Dalfampridine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dalfampridine Market Drivers
1.6.2 Dalfampridine Market Restraints
1.6.3 Dalfampridine Trends Analysis
2 Manufacturers Profiles
2.1 Acorda Therapeutics
2.1.1 Acorda Therapeutics Details
2.1.2 Acorda Therapeutics Major Business
2.1.3 Acorda Therapeutics Dalfampridine Product and Services
2.1.4 Acorda Therapeutics Dalfampridine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Elan Pharma
2.2.1 Elan Pharma Details
2.2.2 Elan Pharma Major Business
2.2.3 Elan Pharma Dalfampridine Product and Services
2.2.4 Elan Pharma Dalfampridine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Biogen
2.3.1 Biogen Details
2.3.2 Biogen Major Business
2.3.3 Biogen Dalfampridine Product and Services
2.3.4 Biogen Dalfampridine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sun Pharmaceutical
2.4.1 Sun Pharmaceutical Details
2.4.2 Sun Pharmaceutical Major Business
2.4.3 Sun Pharmaceutical Dalfampridine Product and Services
2.4.4 Sun Pharmaceutical Dalfampridine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Aurobindo Pharma
2.5.1 Aurobindo Pharma Details
2.5.2 Aurobindo Pharma Major Business
2.5.3 Aurobindo Pharma Dalfampridine Product and Services
2.5.4 Aurobindo Pharma Dalfampridine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Dalfampridine Breakdown Data by Manufacturer
3.1 Global Dalfampridine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Dalfampridine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Dalfampridine
3.4 Market Concentration Rate
3.4.1 Top 3 Dalfampridine Manufacturer Market Share in 2021
3.4.2 Top 6 Dalfampridine Manufacturer Market Share in 2021
3.5 Global Dalfampridine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Dalfampridine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dalfampridine Market Size by Region
4.1.1 Global Dalfampridine Sales in Volume by Region (2017-2028)
4.1.2 Global Dalfampridine Revenue by Region (2017-2028)
4.2 North America Dalfampridine Revenue (2017-2028)
4.3 Europe Dalfampridine Revenue (2017-2028)
4.4 Asia-Pacific Dalfampridine Revenue (2017-2028)
4.5 South America Dalfampridine Revenue (2017-2028)
4.6 Middle East and Africa Dalfampridine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Dalfampridine Sales in Volume by Type (2017-2028)
5.2 Global Dalfampridine Revenue by Type (2017-2028)
5.3 Global Dalfampridine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Dalfampridine Sales in Volume by Application (2017-2028)
6.2 Global Dalfampridine Revenue by Application (2017-2028)
6.3 Global Dalfampridine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Dalfampridine Sales by Type (2017-2028)
7.2 North America Dalfampridine Sales by Application (2017-2028)
7.3 North America Dalfampridine Market Size by Country
7.3.1 North America Dalfampridine Sales in Volume by Country (2017-2028)
7.3.2 North America Dalfampridine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Dalfampridine Sales by Type (2017-2028)
8.2 Europe Dalfampridine Sales by Application (2017-2028)
8.3 Europe Dalfampridine Market Size by Country
8.3.1 Europe Dalfampridine Sales in Volume by Country (2017-2028)
8.3.2 Europe Dalfampridine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Dalfampridine Sales by Type (2017-2028)
9.2 Asia-Pacific Dalfampridine Sales by Application (2017-2028)
9.3 Asia-Pacific Dalfampridine Market Size by Region
9.3.1 Asia-Pacific Dalfampridine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Dalfampridine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Dalfampridine Sales by Type (2017-2028)
10.2 South America Dalfampridine Sales by Application (2017-2028)
10.3 South America Dalfampridine Market Size by Country
10.3.1 South America Dalfampridine Sales in Volume by Country (2017-2028)
10.3.2 South America Dalfampridine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dalfampridine Sales by Type (2017-2028)
11.2 Middle East & Africa Dalfampridine Sales by Application (2017-2028)
11.3 Middle East & Africa Dalfampridine Market Size by Country
11.3.1 Middle East & Africa Dalfampridine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Dalfampridine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Dalfampridine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Dalfampridine
12.3 Dalfampridine Production Process
12.4 Dalfampridine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Dalfampridine Typical Distributors
13.3 Dalfampridine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Dalfampridine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Dalfampridine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Acorda Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Acorda Therapeutics Major Business
Table 5. Acorda Therapeutics Dalfampridine Product and Services
Table 6. Acorda Therapeutics Dalfampridine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Elan Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Elan Pharma Major Business
Table 9. Elan Pharma Dalfampridine Product and Services
Table 10. Elan Pharma Dalfampridine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Biogen Basic Information, Manufacturing Base and Competitors
Table 12. Biogen Major Business
Table 13. Biogen Dalfampridine Product and Services
Table 14. Biogen Dalfampridine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Sun Pharmaceutical Major Business
Table 17. Sun Pharmaceutical Dalfampridine Product and Services
Table 18. Sun Pharmaceutical Dalfampridine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Aurobindo Pharma Major Business
Table 21. Aurobindo Pharma Dalfampridine Product and Services
Table 22. Aurobindo Pharma Dalfampridine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Dalfampridine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Dalfampridine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Dalfampridine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Dalfampridine Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Dalfampridine Production Site of Key Manufacturer
Table 28. Dalfampridine New Entrant and Capacity Expansion Plans
Table 29. Dalfampridine Mergers & Acquisitions in the Past Five Years
Table 30. Global Dalfampridine Sales by Region (2017-2022) & (K Units)
Table 31. Global Dalfampridine Sales by Region (2023-2028) & (K Units)
Table 32. Global Dalfampridine Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Dalfampridine Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Dalfampridine Sales by Type (2017-2022) & (K Units)
Table 35. Global Dalfampridine Sales by Type (2023-2028) & (K Units)
Table 36. Global Dalfampridine Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Dalfampridine Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Dalfampridine Price by Type (2017-2022) & (US$/Unit)
Table 39. Global Dalfampridine Price by Type (2023-2028) & (US$/Unit)
Table 40. Global Dalfampridine Sales by Application (2017-2022) & (K Units)
Table 41. Global Dalfampridine Sales by Application (2023-2028) & (K Units)
Table 42. Global Dalfampridine Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Dalfampridine Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Dalfampridine Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Dalfampridine Price by Application (2023-2028) & (US$/Unit)
Table 46. North America Dalfampridine Sales by Country (2017-2022) & (K Units)
Table 47. North America Dalfampridine Sales by Country (2023-2028) & (K Units)
Table 48. North America Dalfampridine Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Dalfampridine Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Dalfampridine Sales by Type (2017-2022) & (K Units)
Table 51. North America Dalfampridine Sales by Type (2023-2028) & (K Units)
Table 52. North America Dalfampridine Sales by Application (2017-2022) & (K Units)
Table 53. North America Dalfampridine Sales by Application (2023-2028) & (K Units)
Table 54. Europe Dalfampridine Sales by Country (2017-2022) & (K Units)
Table 55. Europe Dalfampridine Sales by Country (2023-2028) & (K Units)
Table 56. Europe Dalfampridine Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Dalfampridine Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Dalfampridine Sales by Type (2017-2022) & (K Units)
Table 59. Europe Dalfampridine Sales by Type (2023-2028) & (K Units)
Table 60. Europe Dalfampridine Sales by Application (2017-2022) & (K Units)
Table 61. Europe Dalfampridine Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Dalfampridine Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Dalfampridine Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Dalfampridine Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Dalfampridine Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Dalfampridine Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Dalfampridine Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Dalfampridine Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Dalfampridine Sales by Application (2023-2028) & (K Units)
Table 70. South America Dalfampridine Sales by Country (2017-2022) & (K Units)
Table 71. South America Dalfampridine Sales by Country (2023-2028) & (K Units)
Table 72. South America Dalfampridine Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Dalfampridine Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Dalfampridine Sales by Type (2017-2022) & (K Units)
Table 75. South America Dalfampridine Sales by Type (2023-2028) & (K Units)
Table 76. South America Dalfampridine Sales by Application (2017-2022) & (K Units)
Table 77. South America Dalfampridine Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Dalfampridine Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Dalfampridine Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Dalfampridine Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Dalfampridine Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Dalfampridine Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Dalfampridine Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Dalfampridine Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Dalfampridine Sales by Application (2023-2028) & (K Units)
Table 86. Dalfampridine Raw Material
Table 87. Key Manufacturers of Dalfampridine Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Dalfampridine Typical Distributors
Table 91. Dalfampridine Typical Customers
List of Figures
Figure 1. Dalfampridine Picture
Figure 2. Global Dalfampridine Revenue Market Share by Type in 2021
Figure 3. 10 mg
Figure 4. Others
Figure 5. Global Dalfampridine Revenue Market Share by Application in 2021
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Dalfampridine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Dalfampridine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Dalfampridine Sales (2017-2028) & (K Units)
Figure 12. Global Dalfampridine Price (2017-2028) & (US$/Unit)
Figure 13. Global Dalfampridine Production Capacity (2017-2028) & (K Units)
Figure 14. Global Dalfampridine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Dalfampridine Market Drivers
Figure 16. Dalfampridine Market Restraints
Figure 17. Dalfampridine Market Trends
Figure 18. Global Dalfampridine Sales Market Share by Manufacturer in 2021
Figure 19. Global Dalfampridine Revenue Market Share by Manufacturer in 2021
Figure 20. Dalfampridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Dalfampridine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Dalfampridine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Dalfampridine Sales Market Share by Region (2017-2028)
Figure 24. Global Dalfampridine Revenue Market Share by Region (2017-2028)
Figure 25. North America Dalfampridine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Dalfampridine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Dalfampridine Revenue (2017-2028) & (USD Million)
Figure 28. South America Dalfampridine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Dalfampridine Revenue (2017-2028) & (USD Million)
Figure 30. Global Dalfampridine Sales Market Share by Type (2017-2028)
Figure 31. Global Dalfampridine Revenue Market Share by Type (2017-2028)
Figure 32. Global Dalfampridine Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Dalfampridine Sales Market Share by Application (2017-2028)
Figure 34. Global Dalfampridine Revenue Market Share by Application (2017-2028)
Figure 35. Global Dalfampridine Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Dalfampridine Sales Market Share by Type (2017-2028)
Figure 37. North America Dalfampridine Sales Market Share by Application (2017-2028)
Figure 38. North America Dalfampridine Sales Market Share by Country (2017-2028)
Figure 39. North America Dalfampridine Revenue Market Share by Country (2017-2028)
Figure 40. United States Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Dalfampridine Sales Market Share by Type (2017-2028)
Figure 44. Europe Dalfampridine Sales Market Share by Application (2017-2028)
Figure 45. Europe Dalfampridine Sales Market Share by Country (2017-2028)
Figure 46. Europe Dalfampridine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Dalfampridine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Dalfampridine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Dalfampridine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Dalfampridine Revenue Market Share by Region (2017-2028)
Figure 56. China Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Dalfampridine Sales Market Share by Type (2017-2028)
Figure 63. South America Dalfampridine Sales Market Share by Application (2017-2028)
Figure 64. South America Dalfampridine Sales Market Share by Country (2017-2028)
Figure 65. South America Dalfampridine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Dalfampridine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Dalfampridine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Dalfampridine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Dalfampridine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Dalfampridine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Dalfampridine in 2021
Figure 77. Manufacturing Process Analysis of Dalfampridine
Figure 78. Dalfampridine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の医薬品用L-グルタミン市場2022年：市場規模予測（～2028年）
  • 世界のオキサゾラム市場2022年：市場規模予測（～2028年）
  • 世界のレナリドミドカプセル市場2022年：市場規模予測（～2028年）
  • 世界のマレヴァン市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用タブレットプレス市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19255 )"世界のダルファンプリジン市場2022年：市場規模予測（～2028年）" (英文：Global Dalfampridine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。